The Journal of Experimental Medicine · 1976 · 107 citations · 10 references
Life SciencesGeneticsImmunologyAdaptive ImmunityImmunogeneticsImmunoregulationAdaptive Immune ResponsesCell-mediated ImmunityEffector T Cell FunctionHelper T Cell SubsetsImmune SuppressionT Cell BiologyAntigen-specific T Cell ResponsesHost Immune SuppressionImmune Suppression MechanismsT Cell-mediated Immune ResponseT Helper CellsT-cell Mediated Immune ResponseT-cell Mediated ImmunityT-cell Mediated Responses
Previous reports from our laboratory have demonstrated the stimulation of specific suppressor T cells in genetic nonresponder mice after immunization with the terpolymer of L- glutamic acid, L-alanine, and L-tyrosine (GAT) (1,2) and with the copolymer of L-glutamic acid and L-tyrosine (GT) (3-5). These findings raise two important questions: (a) do the specific suppressor T cells inhibit an antibody response which would otherwise develop in nonresponder mice; and, (b) can specific helper T cells inhibit an antibody response which would otherwise develop in nonresponder mice; and, (b) can specific helper T-cell activity be detected in these animals. Responsiveness appears to be completely dominant over suppression in (responder x suppressor)F(1) hybrids, therefore, we have been unable to detect suppressor cells in these hybrids after conventional immunization with GAT (2). However , using special conditions of antigen administration, GAT helper activity could be demonstrated in nonresponder DBA/1 ("suppressor") mice. Thus, GAT-specific helper activity was not detected in these nonresponder animals after immunization with GAT irrespective of the adjuvant used, but could be stimulated by macrophage-bound GAT or by GAT complexed with methylated bovine serum albumin GAT-MBSA (6). In the current report we have taken advantage of the fact that suppressor T-cell activity is more sensitive to cyclophosphamide treatment than T-cell helper activity (7) to demonstrate the presence of GT-specific helper activity in "nonresponder" BALB/c mice. We describe: (a) the dose of cyclophosphamide and conditions of treatment which inhibits the well-documented stimulation of specific suppressor T cells in BALB/c mice injected with GT previous to immunization with GT-MBSA, and (b) the ability of cyclophosphamide to permit the development of primary PFC responses to GT in these "nonresponder" mice. These cyclophosphamide-induced responses are not characterized by the high levels of antibody detected in genetic responder animals.
10
GENETIC CONTROL OF IMMUNE RESPONSES IN VITRO
Judith A. Kapp, Carl W. Pierce, Stuart F. Schlossman et al. · The Journal of Experimental Medicine · 1974 · 232 citations · Full text
Life Sciences, Genetics, Immunology +16